Who to call at Edgewise Therapeutics, Inc., and when
Fundz watches for the moments Edgewise Therapeutics, Inc. starts buying, and tells you who to reach.
- An alert the day Edgewise Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Edgewise Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Edgewise Therapeutics, Inc.. With Fundz connected, it knows.
Edgewise Therapeutics, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
edgewisetx.comAI Executive Summary
AI-powered analysis of 8-K filing content
Edgewise Therapeutics appointed Michael Nofi as Chief Financial Officer effective November 10, 2025, succeeding Michael Carruthers, who retired the same day and did not leave over any disagreement with the company. The transition places a finance leader with prior commercialization experience in charge of finances as Edgewise advances late-stage clinical development toward commercialization.
Key Takeaways
Michael Nofi, age 54, takes over as CFO effective immediately, replacing Michael Carruthers, who retired on the same day the change was announced.
Nofi previously served six years as Chief Accounting Officer at SpringWorks Therapeutics (November 2019 to July 2025), where he supported its transition from an R&D organization to a global commercial
2 more takeaways
Related Filings (3)
3 more filings from Edgewise Therapeutics, Inc. in the last 90 days
Filing Overview
What This Means
Edgewise Therapeutics, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.